题目内容

The first gene therapy for an inherited _____ disease was reported by three independent clinical trials in 2008 in patients with Leber's congenital amaurosis (LCA), an early onset retinal dystrophy.

查看答案

搜索结果不匹配？点我反馈

更多问题

Leber's congenital amaurosis (LCA), an early onset retinal dystrophy, is caused by mutations in retinal pigment epithelium-specific protein 65 kDa (RPE65) gene that encodes a _____________________.

Oncorine™, a conditionally replicative adenovirus, was developed by Sunway Biotech Co. Ltd and gained marketing approval in China in ______ in combination with chemotherapy for the treatment of late-stage refractory nasopharyngeal cancer.

In October 2015, FDA approved Imlygic (talimogene laherparepvec) that is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with ____________ recurrent after initial surgery.

The most commonly reported adverse drug reactions (≥25%) in Imlygic-treated patients are _________, chills, pyrexia, nausea, influenza-like illness, and injection site pain.